Skip to main content
Clinical Trials/ACTRN12614000493640
ACTRN12614000493640
Completed
Phase 2

A feasibility study of Integrative medicine for plaque psoriasis combining Chinese herbal medicine with conventional therapy on Psoriasis Area Severity Index (PASI) score and quality of life in people with mild to moderate plaque psoriasis

RMIT University0 sites30 target enrollmentMay 12, 2014

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Plaque psoriasis (psoriasis vulgaris)
Sponsor
RMIT University
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 12, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1 People aged between 18 years and 70 years;
  • 2 People with at least 12 months history of psoriasis vulgaris symptoms diagnosed by physician and where calcipotriol would be appropriate treatment
  • 3 Patient informed consent

Exclusion Criteria

  • 1 Pregnant or breast feeding females;
  • 2 Type of psoriasis other than vulgaris;
  • 3 PASI score \>12 or \<7
  • 4 Patients taking systemic drugs or phototherapy for psoriasis within 4 weeks prior to screening;
  • 5 Taking topical drug treatment for psoriasis within 2 weeks prior to screening
  • 6 Other severe disorders;
  • 7 Known disorders of calcium metabolism (high blood calcium levels);
  • 7 Known kidney function disorders.
  • 8 Taking calcium, vitamin D supplements or vitamin D\-like medicines.
  • 9 Known sensitivity to Chinese herbs.

Outcomes

Primary Outcomes

Not specified

Similar Trials